The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
TheTP53 gene, tobacco exposure, and lung cancer
Open accessAbstract
Of the various genetic alterations in lung cancer, the abnormalities of the TP53 gene (p53) are among the most frequent and important events. Because of its importance, many aspects of TP53 have been studied, including preneoplastic lesions and TP53as a marker for early detection and prognosis and as a therapeutic option. We summarize recent knowledge of TP53 in lung cancer with a special emphasis on the relationship between smoking exposure (e.g, cigarette, etc.) and specific mutational pattern of TP53by analyzing the latest version of the International Agency for Research on Cancer (IARC) database on TP53 mutations in human cancer. Our analysis confirmed several other studies showing significant differences in the frequencies of G:C to T:A transversions between ever-smokers and never-smokers. Furthermore, when comparing the mutational spectrum by gender, important differences were noted between male and female never-smokers. We concluded that the previously noted G:C to T:A transversions were mainly due to female smokers having a high frequency of these changes compared to female never-smokers. There was no relationship between adenocarcinomas and squamous cell carcinomas independent of gender. We also examined the seven codons which have been previously identified as hot spots, that is, the sites of frequent G:C to T:A transversions in smoking-related lung cancers. However, there was no specific codon which was strongly related to smoke exposure despite a moderate relationship. We considered the term "warmspot" may be more appropriate. While mutations of TP53 are frequent in lung cancers, further investigation is necessary to understand their role for lung carcinogenesis, especially as they relate to gender differences, and to translate our laboratory knowledge to clinical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Cancer burden in the year 2000. The global picture
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00267-2 · Cited by 2,169
Peto, R. (2000) · BMJ · doi:10.1136/bmj.321.7257.323 · Cited by 1,409
The IARC TP53 database: new online mutation analysis and recommendations to users
Olivier, M., Eeles, R., Hollstein, M., Khan, M. A., Harris, C. C., & Hainaut, P. (2002) · Human Mutation · doi:10.1002/humu.10081 · Cited by 1,248
p53: A Frequent Target for Genetic Abnormalities in Lung Cancer
Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., & Minna, J. D. (1989) · Science · doi:10.1126/science.2554494 · Cited by 1,197
Self-citationTravis, W. D., Linnoila, R. I., Tsokos, M. G., Hitchcock, C. L., Cutler, G. B., Nieman, L., Chrousos, G., Pass, H., & Doppman, J. (1991) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199106000-00003 · Cited by 880
Differences in Lung Cancer Risk Between Men and Women: Examination of the Evidence
Zang, E. A., & Wynder, E. L. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.3-4.183 · Cited by 722
Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.
Roth, J. A., Nguyen, D., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Ferson, D. Z., Hong, W. K., Komaki, R., Lee, J. J., Nesbitt, J. C., et al. (1996) · Nature Medicine · doi:10.1038/nm0996-985 · Cited by 703
Assessing TP53 status in human tumours to evaluate clinical outcome
Soussi, T., & Béroud, C. (2001) · Nature reviews. Cancer · doi:10.1038/35106009 · Cited by 659
Travis, W. D., Travis, L. B., & Devesa, S. S. (1995) · Cancer · doi:10.1002/1097-0142(19950101)75:1+<191::aid-cncr2820751307>3.0.co;2-y · Cited by 582
TP53 tumor suppressor gene: A model for investigating human mutagenesis
Fromentel, C. C. D., & Soussi, T. (1992) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870040102 · Cited by 574
Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention
Hecht, S. S. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00815-x · Cited by 536
Molecular Damage in the Bronchial Epithelium of Current and Former Smokers
Wistuba, I. I., Virmani, A. K., Gazdar, A. F., Lam, S., LeRiche, J., Behrens, C., Fong, K. M., Samet, J. M., Srivastava, S., & Minna, J. D. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.18.1366 · Cited by 485
Self-citationFujiwara, T., Grimm, E. A., Mukhopadhyay, T., Zhang, W. W., Owen‐Schaub, L. B., & Roth, J. A. (1994) · PubMed · Cited by 464
Detection of oncogene mutations in sputum precedes diagnosis of lung cancer
(1994) · Lung Cancer · doi:10.1016/0169-5002(94)92208-x · Cited by 398
The pathogenesis of mesothelioma
Carbone, M., Kratzke, R. A., & Testa, J. R. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.30227 · Cited by 392
Hainaut, P. (2001) · Carcinogenesis · doi:10.1093/carcin/22.3.367 · Cited by 375
Ahrendt, S. A., Chow, J. T., Xu, L.-H., Yang, S. C., Eisenberger, C. F., Esteller, M., Herman, J. G., Wu, L., Decker, P. A., Jen, J., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.4.332 · Cited by 345
Mitsudomi, T., Hamajima, N., Ogawa, M., & Takahashi, T. (2000) · PubMed · Cited by 341
Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.
Franklin, W. A., Gazdar, A. F., Haney, J., Wistuba, I. I., La Rosa, F. G., Kennedy, T., Ritchey, D. M., & Miller, Y. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119748 · Cited by 330
Self-citationWistuba, I. I., Behrens, C., Milchgrub, S., Bryant, D., Hung, J., Minna, J. D., & Gazdar, A. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202349 · Cited by 329
Self-citationTargeting of Lung Cancer Mutational Hotspots by Polycyclic Aromatic Hydrocarbons
Smith, L. E., Denissenko, M. F., Bennett, W. P., Li, H., Amin, S., Tang, M.-S., & Pfeifer, G. P. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.10.803 · Cited by 307
Harris, C. C. (1996) · Carcinogenesis · doi:10.1093/carcin/17.6.1187 · Cited by 285
Zhang, W. W., Fang, X., Mazur, W. M., French, B. A., Georges, R. N., & Roth, J. A. (1994) · PubMed · Cited by 257
Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.
Sozzi, G., Miozzo, M. R., Donghi, R., Pilotti, S., Cariani, C. T., Pastorino, U., Porta, G., & Pierotti, M. A. (1992) · PubMed · Cited by 250
Genetic changes in the spectrum of neuroendocrine lung tumors
Onuki, N., Wistuba, I. I., Travis, W. D., Virmani, A. K., Yashima, K., Brambilla, E., Hasleton, P. S., & Gazdar, A. F. (1999) · Cancer · Cited by 222
Self-citationp53 Protein accumulates frequently in early bronchial neoplasia
(1994) · Lung Cancer · doi:10.1016/0169-5002(94)90320-4 · Cited by 212
Schuler, M., Herrmann, R., De Greve, J. L. P., Stewart, A. K., Gatzemeier, U., Stewart, D. J., Laufman, L., Gralla, R., Kuball, J., Buhl, R., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1750 · Cited by 210
Rusch, V. W., Klimstra, D. S., Venkatraman, E. S., Oliver, J., Martini, N., Gralla, R. J., Kris, M. G., & Dmitrovsky, E. (1995) · PubMed · Cited by 194
Ramesh, R., Saeki, T., Smyth Templeton, N., Ji, L., Stephens, L. C., Ito, I., Wilson, D. R., Wu, Z., Branch, C. D., Minna, J. D., et al. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0266 · Cited by 193
Kitamura, H., Kameda, Y., Ito, T., & Hayashi, H. (1999) · American Journal of Clinical Pathology · doi:10.1093/ajcp/111.5.610 · Cited by 186
Baptiste, N., Friedlander, P. A., Chen, X., & Prives, C. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205015 · Cited by 168
The UMD-p53 database: New mutations and analysis tools
Béroud, C., & Soussi, T. (2003) · Human Mutation · doi:10.1002/humu.10187 · Cited by 157
Molecular changes in the bronchial epithelium of patients with small cell lung cancer.
Wistuba, I. I., Berry, J., Behrens, C., Maitra, A., Shivapurkar, N., Milchgrub, S., Mackay, B., Minna, J. D., & Gazdar, A. F. (2000) · PubMed · Cited by 148
Self-citationHussain, S. P., Amstad, P., Raja, K., Sawyer, M., Hofseth, L. J., Shields, P. G., Hewer, A. J., Phillips, D. H., Ryberg, D., Haugen, A., et al. (2001) · PubMed · Cited by 147
Ahrendt, S. A., Chow, J. T., Yang, S. C., Li, W., Zhang, M. J., Jen, J., & Sidransky, D. (2000) · PubMed · Cited by 142
Guinee, D. G., Travis, W. D., Trivers, G. E., Benedetti, V., Cawley, H., Welsh, J. A., Bennett, W. P., Jett, J. R., Colby, T. V., Tazelaar, H. D., et al. (1995) · Carcinogenesis · doi:10.1093/carcin/16.5.993 · Cited by 130
p53 and K-ras mutations in lung cancers from former and never-smoking women.
Vähäkangas, K., Bennett, W. P., Castrén, K., Welsh, J. A., Ma, K., Blömeke, B., Alavanja, M. C. R., & Harris, C. C. (2001) · PubMed · Cited by 128
Yuan, A., Yu, C.-J., Luh, K.-T., Kuo, S.-H., Lee, Y.-C., & Yang, P.-C. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.900 · Cited by 126
Nishizaki, M., Fujiwara, T., Tanida, T., HIZUTA, A., Nishimori, H., Tokino, T., Nakamura, Y., Bouvet, M., Roth, J., & Tanaka, N. (1999) · PubMed · doi:10.11501/3168375 · Cited by 118
Payne, S. (2001) · Social Science & Medicine · doi:10.1016/s0277-9536(00)00402-0 · Cited by 117
Human lung cancer and p53 : The interplay between mutagenesis and selection
Rodin, S. N., & Rodin, A. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180320897 · Cited by 106
Absence of p53 Mutations in Malignant Mesotheliomas
Mor, O., Yaron, P., Huszar, M., Yellin, A., Jakobovitz-Picard, O., Brok‐Simoni, F., Rechavi, G., & Reichert, N. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.16.1.8998073 · Cited by 96
Kitamura, H., Kameda, Y., Nakamura, N., Nakatani, Y., Inayama, Y., Iida, M., Noda, K., Ogawa, N., Shibagaki, T., & Kanisawa, M. (1995) · Europe PMC (PubMed Central) · Cited by 93
Kerr, K. M., Carey, F. A., King, G., & Lamb, D. (1994) · The Journal of Pathology · doi:10.1002/path.1711740404 · Cited by 83
Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00339-7 · Cited by 79
Bouck, N. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00005-4 · Cited by 77
TP53 and head and neck neoplasms
Blons, H., & Laurent‐Puig, P. (2003) · Human Mutation · doi:10.1002/humu.10171 · Cited by 77
p53 alterations in atypical alveolar hyperplasia of the human lung
Slebos, R. J. C., Baas, I. O., Clement, M. J., et al. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90448-8 · Cited by 69
Atypical adenomatous hyperplasia of the lung
Montero, C. A., Gimferrer, J. M., & Belda, J. (2000) · Lung Cancer · doi:10.1016/s0169-5002(99)00135-x · Cited by 63
Distribution of p53 and K-ras mutations in human lung cancer tissues
Gao, H. (1997) · Carcinogenesis · doi:10.1093/carcin/18.3.473 · Cited by 59
Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure
Christiani, D. C. (1995) · Lung Cancer · doi:10.1016/0169-5002(96)84239-5 · Cited by 59
Hainaut, P. L. (2001) · Mutagenesis · doi:10.1093/mutage/16.6.551 · Cited by 58
p53 gene mutation analysis in tumors of patients exposed to alpha- particles
Hollstein, M. C. (1997) · Carcinogenesis · doi:10.1093/carcin/18.3.511 · Cited by 49
Molecular abnormalities in lung carcinogenesis and their potential clinical implications
Li, M. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00341-5 · Cited by 44
Mayall, F. G., Jacobson, G. M., & Wilkins, R. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.4.291 · Cited by 39
TP53 mutations in workers exposed to occupational carcinogens: TP53 CARCINOGEN EXPOSURE
Vähäkangas, K. (2003) · Human Mutation · doi:10.1002/humu.10182 · Cited by 37
Norell, S. E. (1995) · doi:10.1093/oso/9780195074901.001.0001 · Cited by 30
p53 gene mutations in asbestos associated cancers.
Liu, B. C., Fu, D. C., Miao, Q., Wang, H. H., & You, B. R. (1998) · PubMed · Cited by 15
Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation
(1993) · Lung Cancer · doi:10.1016/0169-5002(93)90516-z · Cited by 2
Cited by
Shigematsu, H., Lin, L., Takahashi, T., Nomura, M., Suzuki, M., Wistuba, I. I., Fong, K. M., Lee, H., Toyooka, S., Shimizu, N., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji055 · Cited by 2,377
Self-citationLung cancer in never smokers — a different disease
Sun, S., Schiller, J. H., & Gazdar, A. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2190 · Cited by 1,608
Self-citationMutant p53: one name, many proteins
Freed-Pastor, W. A., & Prives, C. (2012) · Genes & Development · doi:10.1101/gad.190678.112 · Cited by 1,247
Rivlin, N., Brosh, R., Oren, M., & Rotter, V. (2011) · Genes & Cancer · doi:10.1177/1947601911408889 · Cited by 1,033
Lung cancer in never smokers – A review
Couraud, S., Zalcman, G., Milleron, B., Morin, F., & Souquet, P.-J. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.03.007 · Cited by 960
Metadata
- Authors
- Toyooka, S., Tsuda, T., & Gazdar, A. F.
- Venue
- Human Mutation
- Publisher
- Hindawi Limited
- Published
- 2003-02-27
- Volume
- 21
- Issue
- 3
- Pages
- 229-239
- ISSN
- 1059-7794 (ISSN-L)
- 1098-1004
- OpenAlex
- W2079713049
- Cited by
- 276
- References
- 62
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.